Related Experiment Video
Updated: Jun 21, 2025
10:44
Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
Published on: May 15, 2019
13.2K
Cereblon E3 Ligase Modulators Mezigdomide and Iberdomide in Multiple Myeloma
Tanvi H Patel1, Frits van Rhee1, Samer Al Hadidi1
1Department of Hematology and Oncology, Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR.
Clinical Lymphoma, Myeloma & Leukemia
|July 13, 2024
Summary
Newer CELMoDs like Mezigdomide and Iberdomide show promise for multiple myeloma (MM) patients. This review explores their mechanisms, efficacy, and safety, offering potential alternatives for relapsed or refractory MM.
Area of Science:
- Hematology
- Oncology
- Pharmacology
Background:
- Multiple Myeloma (MM) is a challenging hematological malignancy with improved outcomes due to current therapies.
- Despite advancements, many MM patients experience relapse, necessitating novel treatment strategies.
- Existing therapies like BCMA-targeted agents have limitations, including side effects and immunosuppression.
Purpose of the Study:
- To review next-generation cereblon E3 ligase modulators (CELMoDs): Mezigdomide and Iberdomide.
- To discuss their biological mechanisms, efficacy, and toxicity profiles.
- To examine ongoing and future clinical trials for these novel MM therapies.
Main Methods:
- Comprehensive literature review of Mezigdomide (CC92480) and Iberdomide (CC-220).
- Analysis of preclinical and clinical data regarding efficacy and safety.
- Evaluation of current and planned clinical trials in multiple myeloma management.
Main Results:
- CELMoDs represent a promising new class of drugs for MM treatment.
- Mezigdomide and Iberdomide demonstrate unique mechanisms of action.
- Further clinical investigation is required to establish their role and optimize patient management.
Conclusions:
- Mezigdomide and Iberdomide offer potential new therapeutic options for relapsed/refractory MM.
- These CELMoDs may address unmet needs where current treatments are insufficient.
- Ongoing trials will define the clinical utility and safety of these agents in MM.
Related Concept Videos
01:15Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
02:34Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
01:10Drugs that Destabilize Microtubules
2.0K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.0K